Cartesian Therapeutics, Inc. (RNAC) income statement
RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.14+0.25 (+4.24%)
Close on Nov 20, 2026Market cap $185.77MP/E –Yield –
Cartesian Therapeutics, Inc. financial ratios
See a number that looks wrong?